Future-Proof Your CDMO


Learn How to Use Data Analytics To Improve Processes and Generate Revenue for your CDMO

Growing competition and the trend toward digitalization in the biopharma industry means that in order to keep up, you need to leverage your CDMO's most important asset: data.

Leveraging your data can help you realize:

  • Quality and Regulatory Assurance through enhanced process understanding and control
  • Increased Partner Trust through increased external collaboration and process transparency
  • Maximized Revenue through COGs optimization and accelerated delivery times


Watch this recent webinar to uncover a competitive advantage

Webinar How Data Analytics can Boost the Bottom Line at a CDMO_38.47


ROI Calculator

Discover how much revenue data analytics could generate.


Try the ROI Tool

CDMO Insights

Get the email series to learn more

How Can CDMOs Unlock the Value of Data?

Data is the new oil. However, just like oil, data needs to be refined and properly put to work. Sartorius Data Analytics is the leading provider of advanced data analytics solutions to the biopharmaceutical industry. Our data refinement offerings include MODDE®, for design of experiments, SIMCA® for multivariate data analysis, and SIMCA®-online for real-time process monitoring.

Get a 30-day Free Trial

DOE Artboard-02

Read More

MVDA Cube Artboard-01

Read More

MVDA Sol_artboard-01

Read More

Book a Free Strategy Session to Learn More

Achieving profitability, growth and staying ahead of competitors means leveraging one of your most important assets: data. As the CDMO market consolidates and becomes more competitive, those who tap into the real value of data can use it to gain recognition as strategic differentiators, provide market leadership, and ultimately become more profitable.

Book a 30 minute strategy session

You will learn:


How to leverage your data  to secure long-time strategic partnerships



How data can be used to maximize profitability


How data can be used to speed up timelines and accelerate delivery

Read More From Our Blog

CDMO webinar crop-1

How CDMOs Can Use Data Analytics as a New Source of Revenue

The global biologics market is one of the fastest growing segments of the pharmaceutical industry. But development and production can’t keep pace with discovery. That’s one reason outsourcing to contract development and manufacturing organizations (CDMOs) continues to increase. 

Read the Blog



How Data Integrity Helps CDMOs Attract Partners

In spite of the increasing level of importance regulatory agencies place on data integrity and security, many small and large CDMOs don’t have the right systems in place to manage their data properly. How can CDMOs move to the next level and digitalized their data management and processes? 

Read the Blog


How CDMOs Can Implement a Modular PAT Strategy

Process analytical technology (PAT) is playing an increasingly important role in the pharmaceutical and biopharmaceutical industries due to regulatory pressure and the push to reduce costs while managing quality. For CDMOs, any investments into PAT technology must be versatile enough to accommodate a variety of products and processes.

Read the Blog

Trending Technologies that Accelerate Process Development for CDMOs

Trending Technologies that Accelerate Process Development for CDMOs

Adopting a strategy that facilitates rapid and reliable development and scale-up of bioprocesses is an urgently growing priority for contract development and manufacturing organizations (CDMOs). The most successful CDMOs have identified strategies for completing projects efficiently and effectively while incorporating QbD approaches.

Read the Blog

Watch a Webinar

Webinar thumb large 750x390_MODDE13_3

How Data Analytics can Boost the Bottom Line at a CDMO

By innovating their service offerings, CDMOs can address some of the major challenges their partners face when deciding to outsource their operations, like loss of control or quality management. In this webinar, we will propose a scenario in which a CDMO can double the return on investment in just one year! 

Watch Now    Download Presentation

OSIsoft and Sartorius Partner to Help CDMOs Leverage their Data

Learn how contract pharma organizations can gain additional insights from their data to become more profitable and increase partner trust. Hear a success story from FUJIFILM Diosynth Biotechnologies, which paired the OSIsoft PI System with advanced data analytics tools to achieve a tenfold optimization in resource expenditure.

Watch Now   Download Presentation

How CDMOs can Adopt a Modular PAT Strategy

When CDMOs investigate the use of PAT they must be assured their ROI, therefore the PAT technology they invest in should be versatile and modular – working with a range of processes and modalities. The Sartorius BioPAT® Spectro Raman tool gives CDMOs working in a high-paced environment the opportunity to unlock the full potential of Raman spectroscopy.

Watch Now  Download Presentation

Putting the “D” in CDMO with Data Analytics and Ambr®

Biopharmaceutical companies have placed an increased reliance on contract development and manufacturing organizations (CDMOs) for all aspects of process development. However, as a CDMO, how can ensure that you’ll be able to meet the aggressive timeline expectations set out by your clients? In this webinar, Sartorius experts will discuss how to accelerate process development timelines. 

Watch Now  Download Presentation

How CDMOs Can Digitalize their Cell and Gene Therapy Processes

One of the most important considerations for companies working in the CGT (cell and gene therapy) field is how to ensure commercial success of the product. By developing a strong relationship with the right CDMO, CGT developers can chart out a development, scale-up, and manufacturing plan that aligns with both their clinical and financial needs.

Watch Now  Download Presentation

Download More Information

Download a customer case story and poster with examples using MODDE, SIMCA and SIMCA-online to improve processes. 


Customer Case Story

FUJIFILM Diosynth Biotechnologies: Enabling Digital Chromatogram Review for a Faster and More Reliable Operation

Download Case Story



Use of Design of Experiments to Define Manufacturing Process Conditions for an ADC

This poster describes the use of design of experiments (DOE) to understand the impact of process parameters at the reactive stages on an ADC product quality attributes. A 24 full factorial design was performed and the results were analyzed via the MODDE© software, with Drug to Antibody ratio (DAR) results shown. 

Download Poster

Development of an ADC Process with Single-Use Membrane Technology

Membrane chromatography is rou􀆟nely used to remove host cell proteins, viral par􀆟cles, and aggregates during an􀆟body downstream processing. The applica􀆟tion of membrane chromatography to the field of an􀆟body-drug conjugates (ADCs) has been applied in a limited capacity and in only specialized scenarios.

Download Poster

Get a Free Consultation

Contact Us Now